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Fulminant Jejuno-Ileitis following Ablation
of Enteric Glia in Adult Transgenic Mice
identified, which target reporter gene expression specif-
ically to astroglia, and have been used to express heter-
ologous genes in transgenic mice (Toggas et al., 1994;
Toby G. Bush,1,2,7 Tor C. Savidge,1,3
Tom C. Freeman,4 Hilary J. Cox,1
Elizabeth A. Campbell,4 Lennart Mucke,5
Johnson et al., 1995). To achieve cellular ablation, weMartin H. Johnson,2 and Michael V. Sofroniew1,2,6
used the thymidine kinase gene of the herpes simplex1Medical Research Council Cambridge Centre
virus (HSV-Tk). Proliferating cells that express trans-for Brain Repair
gene-derived HSV-TK metabolize the antiviral agentForvie Site, Robinson Way
ganciclovir (GCV) to toxic nucleotide analogs, which dis-Cambridge CB2 2PY
turb nucleic acid synthesis and induce cell death (Frank2Department of Anatomy
et al., 1984; Borrelli et al., 1989; Heyman et al., 1989).University of Cambridge
Thus, cell ablation can be regulated in a regionally andDowning Street
temporally specific manner by where and when GCV isCambridge CB2 3DY
administered.3Institute of Child Health
We report here that in transgenic mice expressingUniversity of Birmingham
HSV-TK from the mouse Gfap promoter, the pattern andBirmingham, BI6 8ET
regulation of transgene-derived HSV-TK expression is4Sanger Centre
similar to that of endogenous GFAP, and that transgenicWellcome Trust Genome Campus
astrocytes are vulnerable to GCV in vitro and after CNSHinxton CB10, 1SA
injury in vivo. During initial in vivo studies, we foundUnited Kingdom
that subcutaneous (s.c.) GCV delivery to uninjured adult5Gladstone Molecular Neurobiology Program
transgenic mice was invariably fatal within 19 days inand Department of Neurology
the absence of CNS pathology. We examined vital pe-University of California
ripheral organs for expression of transgene-derivedSan Francisco, California 94141-9100
HSV-TK and for pathological changes. RT-PCR screen-
ing of transgenic mice revealed expression of Gfap and
HSV-Tk in gut, heart, lung, liver, kidney, adrenal, andSummary
spleen. Histopathological examination of these organs
in transgenic animals receiving GCV revealed majorTo investigate the roles of astroglial cells, we targeted
changes only in the gastrointestinal (GI) tract, whichtheir ablation genetically. Transgenic mice were gen-
showed severe inflammation and necrosis of the jeju-erated expressing herpes simplex virus thymidine ki-
num and ileum. Our investigations show that this pathol-nase from the mouse glial fibrillary acidic protein
ogy is related to the ablation of GFAP-expressing enteric(GFAP) promoter. In adult transgenic mice, 2 weeks
glia.of subcutaneous treatment with the antiviral agent
ganciclovir preferentially ablated transgene-express-
Resultsing, GFAP-positive glia from the jejunum and ileum,
causing a fulminating and fatal jejuno-ileitis. This pa-
Generation of HSV-TK Expressing Transgenic Micethology was independent of bacterial overgrowth and
Progeny resulting from the pronuclear injection of awas characterized by increased myeloperoxidase ac-
Gfap-HSV-Tk fusion gene construct were screened fortivity, moderate degeneration of myenteric neurons,
successful integration of the transgene (Figures 1A andand intraluminal hemorrhage. These findings demon-
1B). Transgenic lines were established from three founderstrate that enteric glia play an essential role in main-
mice. Of these, line 7.1 showed the highest expressiontaining the integrity of the bowel and suggest that
of HSV-TK protein in thebrain. Densitometry of Southerntheir loss or dysfunction may contribute to the cellular
blots estimated the number of copiesof transgene incor-mechanisms of inflammatory bowel disease.
porated into the genome of transgenic progeny of line
7.1 to be over 50. Males of line 7.1 were infertile in
agreement with previous reports of male sterility inIntroduction
transgenic mice expressing HSV-TK from other promot-
ers (Al-Shawi et al., 1988). All experimental animals wereAstroglia are among the most numerous cells in all neu-
generated by mating heterozygous females of line 7.1ral systems. Many aspects of their functions are not well
with wild-type males, followed by genotyping by South-understood. To investigate the roles of astrocytes and
ern blot and immunohistochemical demonstration ofrelated astroglia in the central (CNS) and peripheral ner-
HSV-TK expression. Thus, transgenic and nontransgenicvous systems, we targeted their cell death genetically
control animals had similar genetic backgrounds.using the promoter of glial fibrillary acidic protein (GFAP),
Production of HSV-TK protein by transgenic mice wasan intermediate filament protein (Eddleston and Mucke,
demonstrated by Western blot of whole brain extracts1993). Mouse Gfap promoter sequences have been
(Figure 1C) and immunohistochemistry. HSV-TK was
present only in cells with the appearance of astrocytes6 To whom correspondence should be addressed.
(Figures 1D and 1E). In double-labeling studies, HSV-7 Present address: Babraham Institute, Babraham, CB2 4AT, United
Kingdom. TK was always colocalized with GFAP in uninjured mice
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Figure 1. In Vivo Expression of the Gfap-HSV-Tk Transgene
(A) Fusion gene construct of HSV-Tk inserted into exon 1 of the
mouse Gfap gene.
(B) Southern blot of EcoRI-digested genomic DNA from founder
mice (numbers) and nontransgenic littermates (N) hybridized with
an HSV-Tk probe. P, control plasmid.
Figure 2. Vulnerability of Transgenic Astrocytes to GCV in Vitro and
after Injury In Vivo
(A and B) Cell numbers (MTT assay) in primary astrocyte cultures.
(A) Typical experiment. GCV (2 mM, 7 days) significantly (p , 0.001)
reduced cell number in sister culture wells (n 5 3) from a transgenic
mouse (Tg) but not its nontransgenic (NT) littermate. (B) Cumulative
results from 12 transgenic and 12 nontransgenic culture experi-
ments as in (A). GCV significantly reduced the mean number of cells
from transgenic, but not nontransgenic, mice by 75% (ANOVA, p ,
(C) Western blot of whole brain extracts from transgenic and non- 0.001).
transgenic (N) progeny of founder lines 6.5 and 7.1. HSV-TK-purified (C and D) Immunohistochemistry of GFAP in GCV-treated primary
protein (TK) migrates at 45 kDa, with two minor bands 42±44 kDa. astrocyte cultures. Scale bar 5 100 mm. (C) Nontransgenic. Most
A large nonspecific band was present in all brain extracts at 48 kDa. but not all cells are GFAP-positive. GCV had no effect on cell number
(D±G) Immunohistochemistry of hippocampal astrocytes in trans- or appearance. (D) Transgenic littermate to (C) showing severe loss
genic mice, untreated (D±F), or after stab injury (G). Scale bar 5 3 of GFAP-positive cells and relative increase in GFAP-negative cells
mm. (D) Brown single-color staining of HSV-TK heavily labels soma (asterisk).
and nucleus (arrow). (E) Blue single-color staining of GFAP labels (E±H). Immunohistochemistry of GFAP (brown) alone (E and G) or
fibrous processes while soma and nucleus are unstained (arrow). double-staining for GFAP (blue) plus HSV-TK (brown) (F and H) in the
(F and G) Two-color staining of HSV-TK (brown) and GFAP (blue) forebrain of GCV-treated mice 14 days after stab injury (arrowheads).
shows that brown-stained cell bodies and blue-stained processes Scale bar for (E) and (G) 5 35 mm; for (F) 5 12 mm. (E and F)
belong to the same cells. Nontransgenic. GCV had no effect on astrocyte scar formation. (G
and H) Transgenic. GCV has depleted astrocytes from the wound
margins. Neighboring astrocytes have upregulated GFAP and ap-
pear swollen and fragmented (arrows in [H]).or after stab injury to the forebrain, which increased the
number, size, and staining intensity of reactive astro-
cytes (Figures 1F and 1G). HSV-TK was undetectable in
at least 7 days causeda mean cell lossof 75%in culturesnontransgenic littermates.
from transgenic mice but not their nontransgenic lit-
termates (Figures 2A and 2B). ImmunohistochemistryGCV Mediated Killing of GFAP-HSV-TK Transgenic
confirmed the specific loss of GFAP-positive cells andAstrocytes In Vitro and after Brain
showed a relative increase in GFAP-negative cells inInjury In Vivo
GCV-treated transgenic cultures (Figures 2C and 2D).The vulnerability of transgenic astrocytes to GCV was
These findings show that astrocytes from transgenictested in vitro using enriched, subconfluent astrocyte
mice, but not their nontransgenic littermates, were killedcultures from individual neonatal mice, in which about
80% of cells were GFAP-positive. Exposure to GCV for by GCV in vitro, and that diffusion of toxic metabolites
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of GCV produced by transgenic cells was not lethal to
neighboring GFAP-negative cells.
The ability of s.c. GCV to kill astrocytes in vivo was
tested after stab injury to the brain, a procedure known
to upregulate GFAP expression and cause astrocyte
proliferation (Eddleston and Mucke, 1993). Because in
vitro experiments indicated that prolonged exposure to
GCV was needed to achieve substantial ablation of
transgenic astrocytes, GCV was delivered continuously
invivo by s.c. osmoticminipump. The astrocytic reaction
and glial scar induced by stab injury to the forebrain were
robust in GCV-treated nontransgenic mice or untreated
transgenic or nontransgenic mice (n 5 3±6 mice per
group) (Figures 2E and 2F). In contrast, transgenic mice
treated with GCV for 7 or 14 days (n 5 6 per group)
exhibited markedly fewer GFAP and HSV-TK immunore-
active astrocytes adjacent to the wound (Figures 2G
and 2H). The pattern of immunohistochemical staining
at 7 and 14 days suggested that the GCV-induced death
of astrocytes next to the wound margin triggered an
astrocytic reaction in adjacent tissue, where many astro-
cytes looked fragmented, abnormal, and in an early
stage of cell death (Figures 2G and 2H).
Fatality of Chronic s.c. GCV Delivery
to Transgenic Mice
When continuous s.c. GCV treatment was attempted for
longer times, transgenic mice became ill and died within Figure 3. Mortality, Body Weight, and Brain Histology of Transgenic
19 days. This occurred whether or not they had received and Nontransgenic Mice Given Continuous s.c. GCV
a brain injury, and in the absence of weight loss (Figures (A) Probability of survival was not altered by GCV in nontransgenic
(NT) mice but fell steeply in transgenic (Tg) mice after 13 days to3A and 3B).There was no evidence of ptosis, suggesting
reach 0 by 19 days.normal function of the superior cervical ganglion and
(B) Fourteen days of GCV caused less than 7% loss of initial bodysympathetic nervous system, a site of GFAP expression
weight in transgenic mice.in peripheral glial cells. The only external signs of illness
(C±J) Cresyl violet staining and immunohistochemistry for GFAP
were reduced activity and scruffing of the fur. The illness show no difference in the appearance of neurons (C, E, G, and I)
showed a fulminating course that was rapidly fatal. Mori- and astrocytes (D, F, H, and J) in the medulla of untreated (Unt)
nontransgenic (C±F) and moribund GCV-treated transgenic micebund animals were killed in accordance with animal wel-
(G±J). Scale bar for (C), (D), (G), and (H) 5 80 mm; for (E), (F), (I), andfare regulations, and tissue collected for analysis.
(J) 5 5 mm.Transgenic mice treated with GCV for 7 days and
discontinued (n 5 6) survived for 35 days after the start
of GCV (the longest time monitored) and looked healthy. as well as in neural tissues such as brain and trigeminal
ganglion (Figure 4A). No gross or histopathological ab-Transgenic mice treated with GCV for 14 days and dis-
continued (n 5 6) became terminally ill by day 18 after normalities were detected in any major organ in un-
treated transgenic mice (n 5 4 per group) or in non-the start of GCV, indicating that the lethal changes in-
duced in these mice became irreversible between days transgenic mice given GCV for 14 days. Transgenic mice
given GCV for 14 days (n 5 8) also showed no obvious7 and 14. In contrast, s.c. GCV administered continu-
ously for 28 days (the longest time studied) had no de- structural changes to lung, heart, pancreas, kidney,
liver, adrenal, spleen, stomach, or colon. However, thesetectable effects on nontransgenic animals (n 5 6) (Fig-
ures 3A and 3B). mice exhibited pronounced macroscopic changes of
the small intestine in all cases (Figures 4C±4H), whichTo look for potential causes of death, we examined
the CNS in detail, in particular vital centers in the hypo- correlated with a depletion of Gfap and HSV-Tk mRNA
from the small intestine but not other vital organs (Fig-thalamus and brainstem. Uninjured transgenic mice that
received s.c. GCV for 14±17 days (n 5 9) showed little ures 4A and 4B). The GI tract was therefore studied in
greater detail.or no increase in GFAP-immunoreactivity and no evi-
dence of astrocyte loss or neuronal damage throughout
the CNS, compared with similarly processed control Pronounced Inflammation and Necrosis of the
Jejunum and Ileum, Severe Blood Loss,mice (Figures 3C±3J).
In the absence of an obvious cause of death due to and Positive Blood Cultures in
GCV-Treated Transgenic MiceCNS dysfunction, we looked for other sites that might
account for lethality. RT-PCR screening revealed ex- Macroscopic and microscopic examination of the GI
tract in untreated transgenic mice (n 5 6) or in non-pression of Gfap and HSV-Tk in major organs including
heart, lung, liver, spleen, adrenal, kidney, and GI tract, transgenic mice receiving GCV for 11 or 14 days (n 5
Cell
192
6) revealed no evidence of abnormalities (Figures 4C
and 4G; 5A, 5B, 5D, and 5E). In transgenic mice given
GCV for 7 days (n 5 6), the GI tract exhibited small
patches of focal inflammation, but there were no quanti-
tative histopathological changes (Figure 5A), and there
was no occult blood in the stool. In transgenic mice
given GCV for 11 or more days (n 5 18), the fecal con-
tents were black, melanic (Figures 4D, 4F, and 4H±4J),
and tested positively for occult blood. Macroscopically,
the jejunum and ileum exhibited severe inflammation
and hemorrhage, and moderate distension; the duode-
num was not affected severely, and the esophagus,
stomach, and colon appeared normal (Figures 4D, 4E,
4F, and 4H±4K). There was never any evidence of stasis
of gut contents, and in all cases there were normally
formed stool pellets in the colon (Figures 4D, 4F, and
4J). Changes in the small bowel were patchy, appearing
as skip lesions, which varied in severity from small in-
flammatory foci interspersed amongst normal tissue to
large aphthoid and linear ulcers exhibiting gangrenous
necrosis in extreme cases (Figures 4K and 4L). There
was regular evidence of adhesions. The ileum was gen-
erally more severely affected than the jejunum, but
within the ileum, lesions occurred with equal frequency
within the proximal, central, or distal portions. The mu-
cosal surface exhibited many areas of superficial ero-
sion covered with inflammatory exudate and cellular
debris. Microscopic analysis of the jejunum and ileum
revealeda perturbedcrypt-villus architectureand muco-
sal hyperplasia with a statistically significant 50% in-
crease in cryptdepth (Figures5A±5G). Villus atrophywas
not pronounced (Figure 5A), but villi exhibited cellular
abnormalities ranging from mild epithelial changes and
nonspecific granulocytic infiltrate of neutrophils and
other leukocytes (Figures 5F) to marked hemorrhagic
necrosis (Figure 5G). Microscopy confirmed the patchy
nature of the pathology, with abnormal regions immedi-
ately adjacent to more normally appearing areas (Fig-
ures 5C). Pathology appeared to initiate in the villus tips
with flattening, vacuolization, and loss of polarity of the
surface epithelium, loss of the brush border and goblet
cells, interstitial edema separating the epithelium from
the lamina propria, and pronounced dilation of capillar-
ies with erythrostasis (Figures 5D, 5F, and 5G; 8D, 8E,
and 8G). These changes were observed frequently in
the absence of hemorrhage or necrosis, whereas the re-
verse was not encountered. Progressionof these changes
included increased sloughing of epithelial cells and
Figure 4. Effects of GCVon Expression of Gfap and HSV-Tk mRNAs, crypt hyperplasia, increased transmigration of polymor-
and on the Macroscopic Appearance of the GI Tract phonuclear leukocytes leading to granulocytic inflam-
(A and B) RT-PCR of Gfap and HSV-Tk mRNAs in untreated (A) and matory infiltrate of the lamina propria, formation of intra-
GCV-treated (B) transgenic mice. Even loading of cDNA for RT-PCR vascular microthrombi, and fibrosis of, and hemorrhage
is shown by comparable levels of Rps29 amplification. into, the lamina propria (Figures 5F±5H; 8E±8G). In se-
(C±L) Gut specimens from transgenic and nontransgenic mice
verely affected villi, the tips had disintegrated giving risetreated with GCV for 11 (C±J) or 14 (K and L) days.
to a hemorrhagic and inflammatory exudate into the(C and G) Nontransgenic. GCV caused no detectable abnormalities.
bowel lumen (Figures 5C, 5G, and 5H). In severely af-(D, E, F, and H±J) Transgenic. Jejunum and ileum show severe
inflammation and hemorrhage (E, F, H, and I), whereas stomach (D), fected regions, there was inflammation and hemorrhagic
duodenum (E), and colon (F and J) do not. Luminal contents are necrosis of the submucosa and muscularis externa, but
dark and bloody distal to the jejunum (F, H, and I). Stool in the large this pathology was not observed in the absence of
bowel is normally formed but melanic (F and J). (K) Transgenic.
changes to overlying villi (Figures 5D, 5F, and 5G). ThereModerately affected ileum with scattered patches of mural inflam-
was no evidence of cryptitis or crypt abscesses (Figuresmation and hemorrhage. (L) Transgenic. Severely affected ileum
5F±5H). Some areas of severely ulcerated mucosa werewith markedly inflamed and hemorrhagic bowel wall, and ulcers with
gangrenous necrosis (arrows). associated with necrosis of the underlying muscle layer
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Figure 5. Histopathology of the Ileum and
Colon in GCV-Treated Nontransgenic and
Transgenic Mice
(A) Quantitative analysis of small intestine at
five intervals (10%±90%) between the stom-
ach and cecum in four treatment groups:
transgenic mice not treated with GCV (0d Tg)
or treated with GCV for 7 days or 14 days
(7d Tg or 14d Tg), and nontransgenic mice
treated with GCV for 14 days (14d NT). Four-
teen-day Tg showed significantly greater
mean muscle wall thickness and crypt depth
in the mid-to-distal portion (50%±90%) por-
tion of small intestine (corresponding to jeju-
num and ileum) in comparison with the other
treatment groups (p , 0.01, Mann Whitney
U-test). Mean villus height did not differ sig-
nificantly in any treatment group.
(B±J) H and E-stained cross sections of ileum
or colon. (B, D, and E) Ileum of GCV-treated
(11 days) nontransgenic mouse (B and E) is
indistinguishable from untreated (D). (C, F, G,
and H) Ileum of GCV-treated (11 days)
transgenic mice exhibits pronounced disrup-
tion of crypt-villus architecture, with subepi-
thelial interstitial edema (arrows in F), mixed
inflammatory infiltrate, and crypt hyperplasia
(C, F, and G) and hemorrhagic necrosis of the
villi and sub mucosa (G and H). The muscle
wall shows regions of thickening (arrowheads
in C), intramural hemorrhage (arrow in C), and
degeneration beneath mucosal ulceration
(asterisk in C). The bowel lumen contains
hemorrhagic and inflammatory exudate (C)
arising from degenerating villus tips (G, arrow
in [H]). Scale bar for B and C 5 140 mm, for
D±H 5 30 mm. (I and J) Proximal colon of
GCV-treated (11 days) nontransgenic (I) and
transgenic (J) mice are indistinguishable. (J)
derives from the mouse shown in (G). Scale
bar 5 40 mm.
(K) Quantitative analysis of proximal and dis-
tal colon showed no significant difference in
muscle wall thickness or crypt depth (same
treatment groups as in [A]).
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and transmural perforation (Figures 5C). In general, how- (Figures 6E and 6F). Cross sections showed widespread
loss of GFAP-positive glial cells and their processesever, the smooth muscle wall exhibited a qualitatively
obvious and statistically significant 100% thickening from the submucosal regions and the lamina propria of
villi throughout the jejunum and ileum (Figures 6I and(Figures 5A±5C). Other regions of the GI tract, in particu-
lar the colon, appeared microscopically normal by quali- 6J). All regions with histopathological abnormalities ex-
hibited severe loss of glia (Figure 6J). In contrast, thetative and quantitative analysis (Figures 5I±5K).
Blood cell counts and serum chemistry were normal in colon of GCV-treated transgenic mice exhibited either
a small, or no obvious, loss of immunoreactive entericuntreated transgenic mice, in nontransgenic mice given
GCV for 14 days, and in transgenic mice given GCV for glia (Figures 6K and 6L). These findings indicate that
GCV treatment caused a highly selective, severe abla-7 days.Transgenic mice with mild signs of illness after14
days of GCV had red blood cell counts and hemoglobin tion of enteric glial cells from the jejunum and ileum of
transgenic mice, which correlated spatially and tempo-levels reduced to about 60% of normal, with up to 10-
fold elevations of nucleated red blood cells, up to 20- rally with the severe inflammation and hemorrhagic ne-
crosis also induced by this treatment.fold elevations of neutrophils, and mild (about 30%) ele-
vations of serum urea. Moribund GCV-treated transgenic
mice exhibited severe anemia with red blood cell counts Changes of Enteric Neurons in the Jejunum and
Ileum of GCV-Treated Transgenic Miceand hemoglobin levels reduced to less than 25% of
normal, accompanied by high levels of nucleated red In the CNS, GFAP-positive astrocytes provide support-
ive and protective roles for nerve cells (Eddleston andcells and neutrophils relative to the number of red blood
cells, and markedly elevated (.3-fold) serum urea. Mean Mucke, 1993). We therefore looked for effects that abla-
tion of enteric glia might have on enteric neurons. Whole-corpuscular volume and hemoglobin, and the number
of thrombocytes were in the normal range in all animals. mount preparations of jejunum and ileum were double-
labeled for GFAP and cuprolinic blue, a specific markerThese findings ruled out bone marrow failure. Serum
creatinine and other serum chemistry values were also for enteric neurons (Holst and Powley, 1995; Karaosma-
noglu et al., 1996). In control mice (n 5 6), myentericnormal. High levels of serum urea combined with normal
serum creatinine indicate normal kidney function com- neurons were completely enveloped by a dense network
of glial cell processes (Figure 7C). In transgenic micebined with GI bleeding. Bacterial cultures prepared from
blood, peritoneal fluid, and spleen showed no growth treatedwith GCV for 11 days or more (n 5 7), this network
was markedly depleted, with a patchy variation in sever-of gram-negative organisms in control mice whereas
transgenic animals treated with GCV for 14 days showed ity. In areas where some glial cells remained, theneurons
appeared more or less normal and were denuded of.300 colonies per spleen or ml of blood or peritoneal
fluid. Together, these findings were compatible with se- enveloping glial processes to varying degrees (Figure
7D). Where glial cells and processes were largely absent,vere hemorrhage into the intestinal tract and perforation
of the intestine accompanied by bacteremia as causes there was evidence of neuronal atrophy and loss (Figure
7E). To investigate neuronal changes quantitatively, weof acute decline and death in transgenic mice treated
with GCV for 11 days or more. conducted unbiased computer-assisted stereological
analysis of whole-mount specimens prepared under
standardized unstretched conditions, single-stained with
Localization of HSV-TK in GFAP-Positive Enteric cuprolinic blue. This analysis revealed statistically sig-
Glia and Preferential Loss of These Cells nificant differences of 31% fewer myenteric neurons,
from Jejunum and Ileum after GCV and a 27% smaller mean cross-sectional area of re-
Treatment in Transgenic Mice maining neurons, in the ileum of GCV-treated transgenic
To investigate the cause of gut pathology in transgenic mice as compared with controls (Figures 7A and 7B).
mice receiving GCV, the cellular sites of GFAP and HSV- No qualitative or statistically significant evidence of neu-
TK expression were identified in the GI tract by immuno- ronal loss or atrophy was observed in the colon of GCV-
histochemistry. In agreementwith previous studies (Jes- treated transgenic mice (Figures 7A and 7B). Immuno-
sen and Mirsky, 1980; Gershon and Rothman, 1991), histochemistry revealed no detectable difference in the
we observed GFAP-positive enteric glia in an extensive appearance or density of substance P- or tyrosine hy-
network throughout the myenteric and submucosal droxylase-immunoreactive fibers in the ileum (Figures
plexuses in whole-mount preparations and cross sec- 7F and 7G) of GCV-treated transgenic mice (n 5 6) as
tions (Figures 6A and 6G). In addition, we found many compared with controls (n 5 6). Together, these findings
GFAP-positive glia within the lamina propria, with pro- show that ablation of enteric glia caused a moderate
cesses that closely embraced the crypts or extended and patchy, but statistically significant, degeneration of
to the distal-most tips of villi (Figures 6G and 6H). GFAP neurons intrinsic to the ileal myenteric plexus, without
immunoreactivity was not detected in other intestinal obvious structural changes to substance P or sympa-
cell types. In transgenic mice, HSV-TK immunoreactivity thetic innervation.
was present in the nuclei and somata of cells with the
morphological appearance of enteric glia, and double Selective Decontamination of the Digestive Tract
labeling confirmed that HSV-TK was present only in (SDD) Prevents Bacterial Overgrowth but Not
GFAP-positive cells (Figures 6B±6D). After 14 days of Pathological Changes and Inflammation
GCV treatment, there was a pronounced, but incom- in Jejunum and Ileum of GCV-Treated
plete, loss of GFAP- and HSV-TK-positive cells and pro- Transgenic Mice
cesses from the myenteric plexus in the jejunum and Degeneration of enteric neurons can disrupt gut motility
and cause bacterial overgrowth, which in extreme casesileum, and remaining glia had abnormal morphologies
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Figure 6. Cellular Localization of GFAP and
HSV-TK in Ileum of Transgenic Mice before
and after GCV
(A±F) Immunohistochemistry for GFAP (blue)
or HSV-TK (brown) in whole-mount prepara-
tions of ileal myenteric plexus. Scale bar for
(A) and (E) 5 55 mm; for (B), (C), and (F) 5 7
mm; for (D) 5 4.5 mm.
(A±D) Untreated transgenic. GFAP-positive
enteric glia and their processes extend
throughout the myenteric plexus (A). In indi-
vidual plexi, cells stained positively for GFAP
(B) or HSV-TK (C) show similar distributions
and morphologies. Double labeling shows
that HSV-TK is present only in GFAP-positive
cells (D).
(E and F). GCV-treated (14 days) transgenic.
GFAP-positive cells and processes have
been severely depleted (E), and surviving en-
teric glia show abnormal morphologies (F).
(G and H) Untreated nontransgenic. Immuno-
histochemistry of cross and tangential sec-
tions of ileum, showing GFAP-positive enteric
glia and their processes throughout the lam-
ina propria, extending to the most distal villus
tips (G), and densely intertwining between
crypts (H). Scale bar for G 5 30 mm, for H 5
20 mm.
(I±L) Confocal microscopy of immunofluores-
cence for GFAP (green) with propidium iodide
as a nuclear counter stain (red). GFAP-immu-
noreactivity in the ileum is unaltered by GCV
(11 days) in a nontransgenic (I) but is ablated
from the lamina propria of a transgenic (J)
mouse, although small amounts remain in the
myenteric plexus (arrow). GFAP loss is asso-
ciated with thickening of the muscle wall (m),
crypt hyperplasia (c), and epithelial degener-
ation. GFAP-immunoreactivity in the colon
shows no obvious difference in GCV-treated
nontransgenic (K) and transgenic (L) mice.
Scale bar for (I) and (J) 5 25 mm; for (K) and
(L) 5 40 mm.
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showed anaerobic and aerobic colony counts reduced
significantly by more than 1 and 6 orders of magnitude,
respectively, as compared with GCV-treated transgenic
mice not receiving antibiotics (Figures 8Aand 8B). Func-
tional decontamination of the bowel was further demon-
strated by a statistically significant increase (p , 0.01,
t test) of cecal weight relative to body weight in mice
with SDD (2.8 6 0.5%) compared with untreated mice
(1.5 6 0.4%). Aerobic bacterial colony counts were simi-
larly reduced in GCV-treated transgenic mice after 5
days of oral antibiotics (data not shown), indicating ef-
fectiveness of SDD during the entire period of develop-
ment of the intestinal pathology in these mice.
SDD did not reduce the severity of the illnessexhibited
by GCV-treated transgenic mice as judged by the ap-
pearance of the mice, survival time, or severity in the
reduction of hemoglobin levels. The small bowel of GCV-
treated nontransgenic mice with SDD appeared normal;
however, the small bowel of GCV-treated transgenic
mice with SDD exhibited severe macro- and micro-
scopic pathology with mucosal degeneration, capillary
dilation, erythrostasis, granulocytic inflammatory infil-
tration, and hemorrhagic necrosis similar to GCV-treated
transgenic mice that did not receive antibiotics (Figures
8C±8G). Standard microbiological screening and sero-
logical tests showed no evidence of contagious patho-
gens in these mice, such as Clostridium, Salmonella,
Yersina, parasites, and various mouse viruses. These
findings demonstrate that the pathology induced in
transgenic mice by GCV was not merely the result of
bacterial overgrowth in the small bowel, but they do
not rule out a role for bacteria in the etiology of this
pathology.
Myeloperoxidase (MPO) activity deriving from azuro-
philic granules of polymorphonuclear neutrophils was
determined in bowel segments as a specific, quantita-
tive measure of inflammatory response (Miller et al.,
1993). GCV-treated transgenic mice with or without SDD
exhibited substantial and statistically significant in-
creases in MPO activity in ileum, but not duodenum or
colon, compared with GCV-treated nontransgenic mice
with or without SDD (Figure 8C). These findings show
that the pathological changes of the small bowel in GCV-
treated transgenic mice were associated with a pro-
nounced inflammatory infiltrate, which was not pre-
vented by SDD.
Discussion
Enteric glia form a large and widespread network of
cells at all levels of the GI tract. Their functions are not
Figure 7. Effects of Ablation of Enteric Glia on Myenteric Neurons
(A and B) Mean 6 SEM cell number (A) and cross-sectional area
(B) of cuprolinic blue±stained myenteric neurons in whole-mount
preparations of ileum or colon from GCV-treated (11±14 days) non-
transgenic (NT) and transgenic (Tg) mice (n 5 6 for all groups). Tg
mice had significantly (p , 0.001) fewer neurons (A), and remaining
neurons had a significantly (p , 0.001) smaller mean cross-sectional
area (B). There were no significant differences in the colon.
(C±E) Immunohistochemistry of GFAP-containing glia (brown) com-
bined with cuprolinic blue staining of neurons inwhole-mount prepa-
rations of the ileal myenteric plexus. Scale bar 5 10 mm.
(C) Untreated transgenic. Processes from GFAP-positiveenteric glia
envelope all myenteric neurons.
(D and E) GCV-treated (14 days) transgenic. In areas where some
glia remain but exhibit abnormal morphologies, the neurons appear
normal but are denuded of glial processes (D). In areas with near
complete loss of glia, there is neuronal loss and atrophy (E).
(F and G) Immunohistochemistry of tyrosine hydroxylase (F) or sub-
stance P (G) in whole-mount preparations of ileal myenteric plexus
from a GCV-treated (14 days) transgenic, showing densities of fibers
and terminals indistinguishable from untreated mice. Scale bar for
F 5 35 mm, for G 5 15 mm.
may induce inflammatory pathology in the small intes-
tine. We therefore quantitatively assessed bacterial lev- well understood. In this study, we found that ablation
els in gut segments, and examined the effects of SDD of enteric glia in the jejunum and ileum of adult trans-
achieved with oral antibiotics, on the intestinal pathol- genic mice led rapidly to a fulminating enteritis with
ogy triggered by GCV in transgenic mice. The ileum, severe inflammation and hemorrhagic necrosis of these
but not duodenum or cecum, of GCV-treated transgenic organs. Ablation of enteric glia also caused degenerative
mice showed statistically significant 10- to 100-fold in- changes in neural elements of the enteric nervous sys-
creases in the number of anaerobic and aerobic bacte- tem, which may have contributed to the development
rial colonies per gram tissue, respectively, as compared of the associated pathology. The macro- and histo-
with untreated or GCV-treated nontransgenic mice (Fig- pathologic appearance of the small intestine was similar
ures 8A and 8B). The ileum of GCV-treated transgenic to that in experimental models of inflammatory bowel
mice fed diet containing three oral antibiotics (broad disease (IBD) in rodents and in various human condi-
tions.spectrum, antianaerobic, and antifungal) for 14 days
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s.c. GCV Treatment Preferentially and Specifically
Ablated Transgenic Glia in the Jejunum
and Ileum
Most HSV-TK-expressing glial cells throughout the cen-
tral, peripheral, and enteric nervous systems were not
killed in detectable numbers by the regimen of GCV
delivery used in this study. The reason for the preferen-
tial ablation of HSV-TK-expressing glia in the small in-
testine is uncertain. After phosphorylation of GCV by
transgene-derived HSV-TK, GCV-mediated cell death is
thought to result from the formation of toxic intermedi-
ates that disrupt DNA replication and kill proliferating
cells (Frank et al., 1984; Borrelli et al., 1989). In agreement
with these reports, we found that s.c. GCV treatment
killed HSV-TK-expressing CNS astrocytes in vivo only
adjacent to a stab injury, a procedure that induces prolif-
eration of local reactive astrocytes. These observations
suggest that different rates of cell division amongst
HSV-TK-expressing glia may account for variations in
their vulnerability to GCV, but other differences cannot
be ruled out.
In the small intestine, HSV-TK immunoreactivity was
present only in GFAP-positive enteric glia, and not in
other cell types. Enteric glia were clearly ablated in the
jejunum and ileum by GCV treatment, and there is no
evidence to suggest that the lethal metabolites of GCV,
which they produced, had any effects on neighboring
intestinal cells. In previous reports, GCV treatment of
transgenic mice had no toxic effects on non-HSV-TK-
expressing cells that were intermingled with cells which
expressed HSV-TK and died in the pituitary, thyroid,
or stomach (Borrelli et al., 1989; Wallace et al., 1991;
Canfield et al., 1996). In our in vitro experiments, GCV
did not kill GFAP- and HSV-TK-negative cells; instead,
Figure 8. Effects of SDD on the Inflammation and Pathology In-
duced by GCV in Transgenic Mice
(A and B) Mean number 6 SEM of aerobic (A) and anaerobic (B)
colony forming units per gram tissue. GCV-treated (14 days)
transgenic mice (Tg 1 GCV) showed significantly higher counts of
both aerobic and anaerobic bacteria in ileum, but not other gut
regions, compared with untreated, or GCV-treated nontransgenic
(NT 1 GCV), mice. Tg 1 GCV mice given antibiotics for 14 days
(Tg 1 GCV 1 AB) showed significantly fewer aerobic counts in all
three gut regions, and significantly fewer anaerobic counts in ileum
and cecum, compared with untreated or NT 1 GCV mice. (p , 0.01,
ANOVA with Newman-Keuls post hoc pair-wise comparison).
(C) Mean value 6 SEMof myeloperoxidase (MPO) activity expressed
as units per 100 mg protein. Tg 1 GCV and Tg 1 GCV 1 AB mice
showed significantly higher values in ileum but not other gut regions
compared with NT 1 GCV mice or mice treated with NT 1 GCV 1
antibiotics (NT 1 GCV 1 AB). (p , 0.01, ANOVA with Newman-
Keuls).
(D±G) H and E-stained cross sections of villus tips in comparable
regions of midileum. Scale bar for (D)±(F) 5 10 mm; for (G) 5 6.3
mm. (D) NT 1 GCV 1 AB. Healthy columnar epithelium with a promi-
nent brush border and small capillaries in lamina propria. (E) Tg 1
GCV 1 AB. Loss of brush border and epithelial polarity, increased
sloughing of epithelial cells (arrows), and pronounced dilation of
capillaries (c). (F) Tg 1 GCV. Degeneration and vacuolization of
epithelium, sclerosis of lamina propria, formation of microthrombi
in the capillaries (arrowheads), and extravasation of red and white
blood cells. (G) Tg 1 GCV. Severe dilation of a capillary with erythro-
stasis and numerous polymorphonuclear leukocytes including neu-
trophils (n) and monocytes (m).
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these cells increased in number while neighboring GFAP- in the CNS, disruption of glutamate uptake by astrocytes
causes excitotoxic neuronal death (Rothstein et al.,positive, HSV-TK-expressing astrocytes died. Together,
these findings indicate that lethal metabolites of GCV are 1996).
Enteric glia may also influence neural fibers and pro-not released by HSV-TK-expressing cells in sufficient
quantities to kill neighboring cells, and that GCV specifi- jections from enteric neurons. The continuous turnover
of intestinal mucosa due to epithelial sloughing requirescally ablated enteric glia in the small intestine of our
transgenic mice. constant remodeling of enteric neural connections. This
activity is reflected in the constitutive expression by
enteric neurons of GAP-43 (Sharkey et al., 1990). In the
Enteric Glia Play a Fundamental Role adult CNS, astrocytes support some types of sprouting
in Bowel Function or regenerating axons (Kawaja and Gage, 1991). GFAP-
Ablation of enteric glial cells in the jejunum and ileum positive enteric glia that envelop axon bundles (Gershon
led rapidly to severe inflammation and necrosis. The and Rothman, 1991) may play a similar role, with the
persistence of the pathology in mice with SDD showed consequence that loss or dysfunction of enteric glia
that this subacute, necrotizing enteritis was not merely could lead to a failure of certain enteric neural projec-
caused by bacterial overgrowth resulting from disturbed tions.
gut motility due to neuronal degeneration. Thus, func- The widespread distribution of enteric glia and their
tional changes induced by the loss of enteric glia played processes throughout the intestinal mucosa, embracing
a primary role in triggering the disease process. To our crypts and extending to the most distal villus tips, sug-
knowledge, there are no previous reports presenting gests that molecules released from these cells could
evidence for, or postulating, a direct link between the influence many cell types. GFAP-positive glial cells in
loss or dysfunction of enteric glia and pathological the CNS produce, and are affected by, many growth
changes in the bowel. The sequence of events appeared factors and cytokines and participate in inflammatory
to involve early breakdown of the epithelium, and micro- and immune responses (Eddleston and Mucke, 1993),
vascular disturbances. Our observations are also com- a capacity that may be shared by GFAP-positive enteric
patible with a role for normal gut constituents (food glia (Bar et al., 1997). CNS astrocytes also induce blood-
proteins and bacterial flora) in the inflammatory process. brain barrier properties in endothelia (Janzer and Raff,
The rapid inductionof severe intestinal pathologyafter 1987), and some enteric glia display terminal swellings
the ablation of enteric glia demonstrates that these cells resembling the endfeet of CNS astrocytes (Gershon and
play a fundamental role in maintaining the integrity of Rothman, 1991), which often anchor astrocytes to blood
the bowel. Based on comparison with known functions vessels. In this context, it is interesting that ablation of
of related GFAP-expressing glia in other neural systems, enteric glia in this study caused microvascular distur-
there are a number of ways in which enteric glia could bances and certain changes resembling ischemic bowel.
exert powerful effects on bowel function, either by influ-
encing enteric neurons or through direct interactions Changes Induced by Ablation of Enteric Glia
with nonneuronal cell types. Are Similar to IBD
In the CNS, fibrous processes of GFAP-positive astro- The pathological changes induced in our transgenic
cytes surround and contact essentially all types of neu- mice by ablation of enteric glia, although subacute and
rons. Interactions between neurons and glia via these fulminating in nature, bear similarities to IBD in animal
processes show considerable plasticity and play impor- models and various human conditions, in particular
tant roles in regulating neuronal function (Theodosis and Crohn's disease (Strober and Ehrhardt, 1993; Sharkey
MacVicar, 1996). The denuding of myenteric and submu- and Parr, 1996). The features of IBD are of unknown
cosal neurons of glial processes in GCV-treated trans- etiology in human disease (Goyal and Hirano, 1996) and
genic mice is likely to have had a pronounced effect on can be induced to varying degrees in experimental ani-
their function. In other neural tissues, glia also provide mals either by treatment with certain chemicals (Sharkey
important protective and/or supportive functions for and Parr, 1996), the targeted deletion of genes for IL-2,
neurons. In the Drosophila mutant drop dead, glial cell IL-10, or T cell receptors (KuÈ hn et al., 1993; Mombaerts
degeneration precedes, and is thought to cause, neu- et al., 1993; Sadlack et al., 1993), or the genetically tar-
ronal degeneration (Buchanan and Benzer, 1993). In the geted disruption of epithelial adhesion (Hermiston and
mammalian CNS, GFAP-positive astrocytes buffer neu- Gordon, 1995). While these animal models strongly im-
rons from the accumulation of potentially toxic endoge- plicate immune and neural dysfunction in IBD, the cas-
nous molecules and produce neurotrophic growth fac- cade of cellular events remains uncertain.
tors (Eddleston and Mucke, 1993). Our observations Similarities in the appearance of end-stage pathology
demonstrate that loss or dysfunction of enteric glia leads in various bowel conditions suggests that the gut may
to substantial degeneration of myenteric neurons, which have limited ways of responding when it is defective.
may be due to loss of trophic or neuroprotective func- For this reason, it is important to identify single events
tions. Enteric glia produce glial-derived neurotrophic that are able to trigger complex pathological cascades.
factor (GDNF) (Bar et al., 1997), and embryonic mice In this study, loss or dysfunction of enteric glia played a
homozygous for deletion of the genes for GDNF or its primary role in triggering inflammatory bowel pathology,
receptor fail to develop enteric neurons (Moore et al., suggesting that these cells may play a role in IBD. The
1996; Pichel et al., 1996; Sanchez et al., 1996). Enteric enteric nervous system has been implicated in IBD
neurons, like CNS neurons, are vulnerable to glutamate- throughpartial neural degeneration combined with pres-
ervation or increases in proinflammatory peptides suchmediated excitotoxicity (Kirchgessner et al., 1997), and
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Surgical Proceduresas substance P and sympathetic innervation (Goyal and
Surgical procedures were performed under anesthesia with AvertinHirano, 1996; Sharkey and Parr, 1996; McCafferty et al.,
(0.015 ml/g) and halothane. Miniosmotic pumps were implanted1997). Our findings after ablation of enteric glia are
subcutaneously as recommended by the manufacturer (Alzet). Stab
similar. It is interesting that pronounced degenerative injuries to the forebrain were made with a number 11 scalpel blade
changes in the myenteric plexus alone do not precipitate using a rodent stereotaxic apparatus (Kopf, USA).
IBD in experimental animals (Dahl et al., 1987) or in
GCV Administrationpatients with Hirschsprung's disease, suggesting that
GCV (Roche, UK) was administered continuously at a rate of 100imbalance of neural regulation, rather than extensive
mg/kg/day diluted in sterile physiological saline for 7, 14, or 28 daysneuronal degeneration, may be important. As discussed
via subcutaneously implanted osmotic minipumps (Alzet, models
above, the loss or dysfunction of enteric glia may have 1007D, 2001, 2002, or 2004). This dose was reported to kill thyro-
effects on bowel functions other than, and in addition cytes expressing HSV-TK in transgenic mice (Wallace et al., 1991).
to, effects on enteric neurons. We speculate that distur-
Hematology, Serum Chemistry, Bacteriological Analysisbances in enteric glia have the potential to represent a
Blood was collected by cardiac puncture from animals under termi-link between immune, vascular, and neural dysfunctions
nal barbiturate anesthesia. Serum chemistry, hematological analy-in IBD. The pathological changes induced by ablation
ses, and guaiac tests for occult blood in stool were conducted
of enteric glia in the transgenic mice described here by the clinical laboratories of Addenbrooke's hospital, Cambridge.
provide a model for investigating both the etiology and Aerobic bacterial cultures of blood, peritoneal fluid, or organ speci-
potential treatments of IBD and other forms of enteritis. mens (gut, liver, spleen, mesenteric lymph node) were prepared
using either brain heart infusion or blood agar plates. Aerobic and
anaerobic bacteriological analysis of the bowel was performed byExperimental Procedures
BIBRA International (Surrey, UK). Segments of duodenum, ileum,
and cecum in toto were homogenized in Brucella broth, plated ontoGfap-HSV-Tk Fusion Gene Construct
blood agar plates, andgrown under anaerobic or aerobic conditions.Starting with a 15 kb Gfap-lacZ plasmid, the lacZ sequence was
replaced with HSV-Tk sequence (Figure 1A). A 1.7 kb XbaI±Bam HI
SDDfragment, including the HSV-Tk gene and its polyadenylation signal,
SDD was achieved using three antibiotics incorporated into thewas inserted into a pBSII-KS vector (Stratagene). The insert was
diet (Bioserve, Frenchtown, NJ, USA): a broad spectrum antibioticreexcised using Sal I and Not I and ligated into the first exon of a
(ciprofloxacin, 0.5 mg/g), an antianaerobic agent (metronidazole,Gfap promoter cassette (clone 445) consisting of a modified murine
0.25 mg/g), and an antifungal agent (fluconazole, 0.2 mg/g), whichGfap gene (Johnson et al., 1995). Integrity of the HSV-Tk insert and
retain high concentrations in feces and are used to control bacterialflanking regions was confirmed by single-strand sequencing. The
number in the GI tracts of neutropenic patients. Mice consumedGfap-HSV-Tk fusion gene construct was excised by digestion with
3±6 g per day.SfiI and purified by gel electrophoresis.
MPO Assay
Animals MPO activity from polymorphonuclear neutrophils was assayed
Mice werehoused in a 12 hr light/dark cycle with controlled tempera- (Miller et al., 1993) in bowel segments (100±250 mg), homogenized,
ture and humidity, and allowed free access to food and water. and centrifuged at 20,000 g. Pellets were resuspended, pseudoper-
Transgenic mice were produced using standard techniques (Hogan oxidase activity negated with hexadecyltrimethlammonium bro-
et al., 1986). Approximately 2 pl of DNA (500 copies of linearized mide, followed by 3 cycles of sonication, freezing, and thawing.
fusion gene construct) were pressure injected into the male pronu- Supernatant (10 ml) was mixed with 90 ml of potassium phosphate
cleus of fertilized eggs from superovulated female C57BL/10 3 CBA buffer containing O-dianisidine dihydrochloride and H2O2 and absor-
mice mated with CFLP males (Interfauna, UK). Two-cell stage eggs bence determined at 450 nm. One U of MPO activity was defined
were reimplanted into pseudopregnant foster mothers. DNA ob- as that required to degrade 1 mmol of H2O2 per min at 258C. Values
tained by tail biopsy from resulting mice was digested with EcoRI were expressed as MPO units per 100 mg total protein per sample.
and screened by Southern blot using a 1.7 kb HSV-TK probe.
Tissue Harvest
Western Blot Mice were killed by terminal barbiturate anesthesia. Dissected tis-
Frozen cerebral hemispheres were freeze/thawed, homogenized in sues were either frozen in liquid nitrogen and stored at 2708C until
lysis buffer (20 mM HEPES [pH 7.5], 0.42 M NaCl, 1.5 mM MgCl2 PCR or sectioning, or fixed in 4% paraformaldehyde and processed
0.2 mM EDTA, 0.5 mM PMSF, 0.25 mM DTT, 50 mM NaF, 1 mM for hematoxylin and eosin (H and E)-stained paraffin sections. Some
sodium orthovanadate, and 20% glycerol [w/v]), and centrifuged at mice were fixed by transcardiac perfusion and frozen sections pre-
10,000 g. Supernatant proteins were separated on SDS PAGE and pared.
transferred to nitrocellulose membrane. Nonspecific binding sites
were blocked with 5% milk powder, followed by incubation in 1:250 RT-PCR
rabbit anti-HSV-TK (P. Collins), 1:250 biotinylated anti-rabbit IgG Total RNA was extracted from frozen tissues and reverse tran-
(Dako), streptavidin-biotin-horseradish peroxidase complex (ABC; scribed. PCR primers were: Gfap (accession number K01347, for-
Vector), and diaminobenzidine (0.5 mg/ml). ward GTT GTG AAG GTC TAT TCC TGG C; reverse TCC CTT AGC
TTG GAG AGC AA); HSV-Tk (forward GGT CCC GGA TCC GGT GGT
GG; reverse CGA GGC GGT GTT GTG TGG TGT); ribosomal proteinIn Vitro Experiments
S29 (Rps29, accession number L31609, forward CTG ATC CGC AAAPrimary astrocyte cultures were prepared from brains of individual
TAC GGG; reverse GCA TGA TCG GTT CCA CTT G). Primers wereneonatal (,48-hr-old) littermate pups (McCarthy and deVellis, 1980).
used at 100 ng/reaction. Hot-lid PCR amplification of cDNA wasEach culture was genotyped by Southern blot of corresponding liver
carried out in PCR buffer containing 0.5 mM dNTPs and 0.6 U Ampli-DNA. Astrocyte vulnerability to GCV was assessed using the MTT
Taq DNA polymerase on PTC-225 thermal cyclers (Tetrad). PCR(3-[4,5-Dimethylthylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) as-
products were separated on agarose gel and stained with ethidiumsay (Hansen et al., 1989). Sister cultures were grown in triplicate in
bromide.the presence or absence of 2 mM GCV for up to 7 days. For the
assay, medium was replaced by MTT solution (0.5 mg/ml in PBS)
for 3 hr; cells were lysed with SDS, and OD measured at 570 nm. For Immunohistochemistry and Histology
Pieces of GI tract tissue, or 40 mm thick frozen forebrain sectionsimmunohistochemistry, cultures were fixed in 4% paraformaldehyde
and stained as described below for tissue sections. were stained free-floating in primary antibody overnight, biotinylated
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secondary antibody for 2 hr, streptavidin-biotin-horseradish peroxi- Gershon, M.D., and Rothman, T.P. (1991). Enteric glia. Glia 4,
195±204.dase complex (ABC, Vector) for 2 hr, and diaminobenzidine (DAB,
0.5 mg/ml). For double labeling, sections were stained sequentially Goyal, R.K., and Hirano, I. (1996). The enteric nervous system. N.
using DAB as a brown chromagen followed by Vector SG (Vector) Engl. J. Med. 334, 1106±1115.
to give a blue color. GFAP was also visualized using streptavidin- Gundersen, H.J.G., Bendtsen, T.F., Korbo, L., Marcussen, N., Moller,
FITC (1:100) with propidium iodide (5 mg/ml) as a nuclear counter- A., Nielsen, K., Nyengaard, J.R., Pakkenberg, B., Sorensen, F.B.,
stain and viewed by confocal laser scanning microscopy (Bio-Rad Vesterby, A., and West, M.J. (1988). Some new, simple and efficient
MRC500). Rabbit primary antibody dilutions were: anti-HSV-TK steriological methods and their use in pathological research and
1:25,000 (P. Collins), anti-GFAP 1:25,000 (Dako); anti-TH 1:25,000 diagnosis. APMIS (Copenhagen) 96, 379±394.
(Dako); anti-substance P1:25,000 (Dako). Enteric neuronswere visu-
Hansen, M.B., Nielsen, S.E., and Berg, K. (1989). Re-examinationalized with cuprolinic blue alone or in combination with immunohis-
and further development of a precise and rapid dye method for mea-tochemistry (Holst and Powley, 1995; Karaosmanoglu et al., 1996).
suring cell growth/cell killing. J. Immunol. Methods 119, 203±210.
Hermiston, M.L., and Gordon, J.I. (1995). Inflammatory bowel dis-Morphometry
ease and adenomas in mice expressing a dominant negativeSmooth muscle wall thickness, crypt depth, and villus height were
N-cadherin. Science 270, 1203±1207.measured by image analysis (Seescan) in H and E-stained paraffin
Heyman, R.A., Borrelli, E., Lesley, J., Anderson, D., Richman, D.D.,sections. Enteric neuron counts and cross-sectional area measure-
and Baird, S.M. (1989). Thymidine kinase obliteration: creation ofments were performed in cuprolinic blue±stained whole-mount
transgenic mice with controlled immune deficiency. Proc. Natl.specimens using stereology and unbiased sampling (Gundersen et
Acad. Sci. USA 86, 2698±2702.al., 1988). Tissue preparations were fixed unstretched in a standard-
ized manner. Care was taken not to introduce postmortem stretch Hogan, B., Constantini, E., and Lacy, E. (1986). Manipulating the
artifacts, which might influence cell counts (Karaosmanoglu et al., Mouse Embryo: A Laboratory Manual (Cold Spring Harbor, New
1996). Two counting frame fields (8564 mm2) per mm2 were selected York: Cold Spring Harbor Laboratory Press).
at random using a computer-driven microscope stage (CAST, Olym- Holst, M.C., and Powley, T.L. (1995). Cuprolinic blue (quinolinic
pus). Since whole-mount preparations are thin and unsectioned, all phthalocyanine) counterstaining of enteric neurons for peroxidase
neurons identifiable through the depth of the specimen were ana- imunocytochemistry. J. Neurosci. Methods 62, 121±127.
lyzed per frame. At least 15 mm2 were analyzed, at least 200 neurons
Janzer, R.C., and Raff, M.C. (1987). Astrocytes induce blood-brainwere counted, and the cross-sectional area of at least 60 neurons
barrier properties in endothelial cells. Nature 325, 253±256.was measured for each gut segment per animal.
Jessen, K.R., and Mirsky, R. (1980). Glial cells in the enteric nervous
system contain glial fibrillary acidic protein. Nature 286, 736±737.Acknowledgments
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